Literature DB >> 25297502

On-pump versus off-pump coronary artery bypass surgery in high-risk patients.

Qiang Ji1, YunQing Mei, Xisheng Wang, Wenjun Ding.   

Abstract

This study aimed to evaluate on-pump versus off-pump coronary artery bypass grafting (CABG) in patients with a high-risk operative profile.The pre-, intra- and post-operative data of high-risk patients with additive European system for cardiac operative risk evaluation (additive Euro-SCORE) over 6 undergoing isolated CABG from January 2008 to December 2011 in this center were investigated and retrospectively analyzed. Using the propensity score-matching method, those patients with similar pre- and intra-operative characteristics were selected and their early clinical outcomes were compared.From January 2008 to December 2011, 485 consecutive patients (398 males, with a mean age of 70.9 ± 9.0 years) whose additive Euro-SCORE was over 6 were entered into this study. Off-pump coronary bypass grafting (OPCAB) was performed in 58.1% (n = 282), and the remaining patients underwent conventional coronary artery bypass grafting (CCABG). After propensity score matching, the two groups of patients (90 OPCAB patients versus 90 CCABG patients) were similar with regard to pre- and intra-operative characteristics but not duration of surgical procedure. No significant differences in hospital mortality were found. Compared to CCABG, high-risk patients undergoing OPCAB had significantly lower prevalence of postoperative respiratory failure and postoperative renal failure (6.7% versus 17.8%, P = 0.0386, 5.6% versus 16.7%, P = 0.0307, respectively). Through multivariate logistic regression analysis, type of procedure (CCABG versus OPCAB), as an independent risk factor, had an impact on the postoperative respiratory failure (OR = 2.36, 95%CI 1.44-4.97, P = 0.0312) and postoperative renal failure (OR = 2.86, 95%CI 1.61-5.81, P = 0.0037).Compared with CCABG, OPCAB reduced postoperative respiratory and renal morbidity in high-risk patients.

Entities:  

Mesh:

Year:  2014        PMID: 25297502     DOI: 10.1536/ihj.14-088

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  6 in total

1.  Factors Associated with Intubation Time and ICU Stay After CABG.

Authors:  Suzanny Flegler; Flavia Marini Paro
Journal:  Braz J Cardiovasc Surg       Date:  2015 Nov-Dec

2.  Surgical Endoepicardial Linear Ablation for Ventricular Tachycardia With Postinfarction Left Ventricular Aneurysm.

Authors:  Changcheng Liu; Zhaoping Su; Liangshan Wang; Bo Li; Jin Wang; Yang Yu; Chengxiong Gu
Journal:  Tex Heart Inst J       Date:  2020-06-01

3.  Patients over 70 years of age with moderate ischemic mitral regurgitation undergoing surgical revascularization plus mitral valve repair: insights from a single-center study of propensity-matched data.

Authors:  Qiang Ji; Xiao-Min Qi; Jin-Qiang Shen; Yu-Lin Wang; Ye Yang; Wen-Jun Ding; Li-Min Xia; Chun-Sheng Wang
Journal:  Cardiovasc Diagn Ther       Date:  2019-12

4.  Perioperative care in elderly cardiac surgery patients.

Authors:  Ewa Kucewicz-Czech; Katarzyna Kiecak; Ewa Urbańska; Tomasz Maciejewski; Robert Kaliś; Waldemar Pakosiewicz; Tadeusz Kołodziej; Piotr Knapik; Roman Przybylski; Marian Zembala
Journal:  Kardiochir Torakochirurgia Pol       Date:  2016-12-30

5.  Early clinical outcomes of on-pump beating-heart versus off-pump technique for surgical revascularization in patients with severe left ventricular dysfunction: the experience of a single center.

Authors:  LiMin Xia; Qiang Ji; Kai Song; JinQiang Shen; YunQing Shi; RunHua Ma; WenJun Ding; ChunSheng Wang
Journal:  J Cardiothorac Surg       Date:  2017-02-23       Impact factor: 1.637

6.  Elderly Patients with Moderate Chronic Ischemic Mitral Regurgitation: Coronary Artery Bypass Grafting Alone or Concomitant Mitral Annuloplasty?

Authors:  Qiang Ji; Yun Zhao; JinQiang Shen; YuLin Wang; Ye Yang; LiMin Xia; Kai Song; ChunSheng Wang
Journal:  Cardiol Res Pract       Date:  2019-12-18       Impact factor: 1.866

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.